Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR-80.1%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-80.1%/yr
Annual compound
Percentile
P64
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202510.24%
2024-6.78%
202310.91%
20221293.98%
2021-64.97%
20200.00%
2019-100.00%
2018-99.41%
2017155.14%
2016-77.20%